IP Library Granted Patent US 12,167,742
Granted Patent B2
US 12,167,742 · App. 17/416,578 · Granted Dec 17, 2024

Nutritional composition comprising 6′SL and LNT in combination to improve the gastrointestinal barrier function

Inventors: Sami Damak (Lausanne, CH); Francis Foata (La Conversion, CH); Norbert Sprenger (Savigny, CH)
Assignee: Societe des Produits Nestle S.A.
A23L33/40A23L33/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,167,742
App. No.
17/416,578
Granted
Dec 17, 2024
Kind
B2
Abstract

The present invention relates to nutritional compositions comprising 6′-sialyllactose (6′SL) and lacto-N-tetraose (LNT) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gut barrier function in an infant, a young child or children aged above 3 years to 8 years.

Claims (16)

1. A method of improving a gastrointestinal barrier in an infant, young child or child, the method comprising administering a nutritional composition comprising 6′-sialyllactose (6′SL) and lacto-N-tetraose (LNT) to the infant, young child or child,

wherein the improving the gastrointestinal barrier comprises at least one of improving barrier structure and/or improving barrier protection,

wherein the nutritional composition has at least one formulation that is: (i) the nutritional composition does not contain DFL and does not contain 3-FL, and/or (ii) the nutritional composition does not contain LNnT, and/or (iii) the nutritional composition does not contain 3′-SL.

2. The method according to claim 1 , wherein the improving the gastrointestinal barrier further comprises improving recovery of integrity of the gastrointestinal barrier.

3. The method according to claim 1 , wherein the method is further for at least one of improving strength of the gastrointestinal barrier, improving the gastrointestinal barrier resistance, reducing disease susceptibility, reducing severity of symptoms upon inflammatory challenge of gastrointestinal mucosa and/or reducing the gastrointestinal barrier permeability.

4. The method according to claim 3 , wherein the reducing the gastrointestinal barrier permeability comprises reducing at least one of pathogens, allergens and/or toxic compounds migrating from gut into body through intestinal barrier in the infant, young child or child.

5. The method according to claim 1 , wherein the nutritional composition is formulated for administering to an infant.

6. The method according to claim 5 , wherein the infant is selected from the group consisting of premature, small for gestational age and low birth weight babies.

7. The method according to claim 1 , wherein the 6′SL and the LNT are present in a weight ratio of 6′SL:LNT from 3:1 to 1:3.

8. The method according to claim 1 , wherein the 6′SL is present in an amount of 0.005 to 5 g/L of the nutritional composition on a dry weight basis.

9. The method according to claim 1 , wherein the LNT is present in an amount of 0.005-3 g/L or 0.004-2.3 g/100g of nutritional composition on a dry weight basis.

10. The method according to claim 1 , wherein

a) the 6′SL is present in an amount of 0.24 or 0.05 g/L of the nutritional composition or in an amount of 0.18 or 0.04 g/100g of the nutritional composition on a dry weight basis; and/or

b) the LNT is present in an amount of 0.5 g/L or 0.1 g/L of the nutritional composition or in an amount of 0.38 g/100g or 0.08 g/100g of the nutritional composition on a dry weight basis.

11. The method according to claim 1 , wherein the nutritional composition is selected from the group consisting of an infant formula, a starter infant formula, a follow-on or follow-up infant formula, a growing-up milk, a baby food, an infant cereal composition, a fortifier and a supplement.

12. The method according to claim 6 , wherein the infant was born premature.

Assignments (2)
MERGER Recorded Sep 3, 2024
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 068472/0207 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2024
From: DAMAK, SAMI; FOATA, FRANCIS; SPRENGER, NORBERT
To: NESTEC S.A.
Reel/Frame 068826/0813 →
Priority Claims (1)
EP 18215378 · Dec 21, 2018 · regional
Continuity (1)
Related Publication 20220287349A1 · Sep 15, 2022